GenomesDAO is standing out from the crowd by selling NFTs with a whole-genome sequencing kit. The NFT project – Geneticats – is not just another cat project; it’s highly innovative as it focuses on unique, genomic data.
GenomesDAO is a biotech DAO that supports the safe, private and auditable monetisation of genomic data. The DAO is merging encryption technology (AMD-SEV Vaults) with the blockchain in order to create a decentralized data brokering platform. What distinguishes this project is that users have full custody and control over their genomic data.
What is Geneticats?
GenomesDAO’s NFT is called Geneticats. Sure, it is a cat NFT, but mathematical inputs based on the holder’s genome generate each individual NFT. It is, therefore, a one-of-one cat NFT that’s unique to each and every NFT holder.
Interestingly, GenomesDAO does not care about the floor price. This is because the DAO intends to personalize this NFT due to the use of genetic content. Each Geneticats NFT comes with a genome sequencing kit, which can be redeemed through the EtherCards platform. Depending on the rarity of the NFT, some have more than one redeemable feature – such as tokens, etc.
So how does GenomesDAO’s genome sequencing work?
Every NFT holder receives a swab test by post. They have to swab their cheek and send the sample back to GenomesDAO. Each user has his or her details securely uploaded to a self-custody Genome Vault. Only the NFT owner can access that data. In addition, NFT holders can make money from their genome sequence by accepting requests from partner pharmaceutical companies that pay the user in $GENE – the official token.
The rise of scientific DAOs such as GenomesDAO, allows people to take back control of their data and monetise it on their own terms. Late last year, artist Rachel Rossin was one of the first people to mint her DNA. It’s safe to say that what seemed to be an absurd idea quickly gained ground.